Previous close | 8.30 |
Open | 8.30 |
Bid | 8.09 x 200 |
Ask | 8.13 x 100 |
Day's range | 8.01 - 8.31 |
52-week range | 6.06 - 14.07 |
Volume | |
Avg. volume | 681,441 |
Market cap | 440.588M |
Beta (5Y monthly) | 0.98 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Q1 2024 Voyager Therapeutics Inc Earnings Call
Discover how Voyager Therapeutics Inc (VYGR) is advancing its neurogenetic medicine pipeline and strengthening financial stability through strategic collaborations.
Voyager Therapeutics (VYGR) delivered earnings and revenue surprises of 54.55% and 88.87%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?